Being Alive Newsletter; December 1992
Walt Senterfit
Preliminary results indicate that both a combination (roughly half the usual dose of each one given every day) or an alternating (full dose of each on alternate days) regimen was free of the kidney toxicity associated with foscarnet about 30% of the time. However, a severe reduction of white blood cells (the major toxicity of ganciclovir) was still relatively high on the combination regimen, but much less so on the alternating one. The effectiveness in preventing relapse seems greater with either of these regimens than with one or the other drug alone, but full results aren't yet available. Overall, it seems likely that using both, particularly in the alternating mode, may be a distinct improvement over one-drug therapy for many people while we await the badly needed better anti-CMV drugs.
921201
BA921209
Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/